Your browser doesn't support javascript.
loading
SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.
Ceriani, Luca; Gritti, Giuseppe; Cascione, Luciano; Pirosa, Maria Cristina; Polino, Angela; Ruberto, Teresa; Stathis, Anastasios; Bruno, Andrea; Moccia, Alden A; Giovanella, Luca; Hayoz, Stefanie; Schär, Sämi; Dirnhofer, Stefan; Rambaldi, Alessandro; Martinelli, Giovanni; Mamot, Christoph; Zucca, Emanuele.
Afiliação
  • Ceriani L; Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Gritti G; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Cascione L; Hematology Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Pirosa MC; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Polino A; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Ruberto T; Medical Oncology Clinic, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Stathis A; Medical Oncology Clinic, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Bruno A; Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Moccia AA; Medical Oncology Clinic, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Giovanella L; Department of Nuclear Medicine, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Hayoz S; Medical Oncology Clinic, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Schär S; Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Dirnhofer S; Division of Nuclear Medicine, University Hospital and University of Zurich, Zurich, Switzerland.
  • Rambaldi A; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • Martinelli G; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
  • Mamot C; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Switzerland.
  • Zucca E; Hematology Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Blood Adv ; 4(6): 1082-1092, 2020 03 24.
Article em En | MEDLINE | ID: mdl-32196557
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article